1/79
Stabinsky
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
background
some drugs can lower the seizure threshold and should be avoided in someone with a seizure history
epilepsy is a chronic seizure disorder
seizure symptoms vary from uncontrolled jerking movements (tonic-clonic seizure) to a subtle momentary loss of awareness (absence seizures)
an ECG is the most common test used to diagnose epilepsy
key drugs that can cause seizures
analgesics --> opioids (especially tramadol, meperidine)
anti-infectives --> quinolones, carbapenems, cephalosporins, penicillins, mefloquine
psych meds --> bupropion, antipsychotics (esp. clozapine), lithium, TCAs
classification of seizure types
focal seizures start on one side of the brain but can spread to the other side
generalized seizures start on both sides
focal aware seizure --> no loss of consciousness
focal seizure with impaired awareness --> loss of consciousness
rigid and tense muscles --> tonic
generalized seizures with non-motor symptoms are called absence seizures
acute seizure managements
status epilepticus is a seizure that lasts 5 minutes or more --> medical emergency
initial treatment is a benzo injection
if not able to get IV access, midazolam can be given IM
if patient is not receiving urgent medical care, diazepam rectal gel is an option
status epilepticus treatment
stabilization phase 0-5 minutes -->
- stabilize circulation, airway, and breathing
- time the seizure, start ECG
- check ASM levels and electrolytes
- if blood glucose is low, treat with dextrose
initial treatment phase 5-20 minutes -->
- if seizures continue, give IV lorazepam, IM midazolam, or IV diazepam
- alternatives: rectal diazepam, intranasal or buccal midazolam
second treatment phase 20-40 minutes -->
- if seizures continue, give nonbenzo ASM: IV fosphenytoin, valproic acid, or levetiracetam
- alternative: IV phenobarbital
third treatment phase (refractory) -->
- no clear evidence to guide therapy
- repeat second-line treatment or midazolam, phenobarbital, or propofol
**** diastat acudial is prescribed for patients who are at risk of long-lasting seizures
diastat acudial
each package contains two rectal syringes prefilled with diazepam rectal gel
each syringe MUST be dialed to the right dose and locked BEFORE DISPENSING
syringes come in 2.5, 10, and 20mg
pharmacist instructions for locking in the dose are included on a card in the package
- hold the barrel of the syringe in one hand with the cap facing down and the dose window visible. do not remove the cap
- use the other hand to grab the cap firmly and turn to adjust the dose
- confirm the correct dose shows in the window. hold the locking ring at the bottom of the syringe barrel and push upward on both sides of the ring. Once locked, the green band should say "READY" and the syringe cannot be unlocked
- repeat these steps with the second syringe in the case. when counseling, check both syringes with the patient before they leave the pharmacy to ensure they are dialed and locked.
chronic seizure management
ASMs should NOT be stopped abruptly as this can lead to increased seizures
medical marijuana
epidiolex, or cannabidiol (CBD), was the first cannabis-derived medication approved by the FDA to treat rare forms of epilepsy
ketogenic diet
can be used in patients with refractory seizures
usually contains a 4:1 ratio of fate to combined protein and carbs
this elevated ketone state is called ketosis, and can lead to a reduction in seizure frequency
antiseizure meds
broad-spectrum ASMs treat both focal and generalized seizures
a few ASMs are used for isolated conditions, such as ethosuximide for absence seizures
common concerns with ASMs
CNS and psych effects
bone loss
rash
CNS and psych effects
all ASMs increase the risk of CNS depression (confusion, sedation) and increase the risk for cognitive impairment and falls
all ASMs also have a warning for suicide risk and require monitoring for changes in mood
bone loss
ASMs increase fracture risk
all patients on ASMs should be supplemented with calcium and vitamin D
rash
increased risk of SJS and TEN
DRESS is a multiorgan HSR
take your vitamins with ASMs, supplement with:
all ASMs --> calcium and vitamin D
women of child bearing age --> folate
valproic acid --> possibly carnitine
lamotrigine and valproic acid --> if alopecia develops, supplement with biotin, selenium, and zinc
ASM description
seizures can occur due to a deficiency of the inhibitory NT, GABA, or an excess of the excitatory NT, glutamate
ASMs work by either increasing GABA, or decreasing glutamate
what drugs enhance GABA effect
benzos
phenobarbital
what drugs block sodium channels and increase GABA
valproate
what drugs inhibit vesicle fusion by binding SV2A proteins
levetiracetam
what drugs block sodium channels
carbamazepine
phenytoin/fosphenytoin
topiramate
what drugs block sodium channels and decrease glutamate
lamotrigine
what drugs block T-type calcium channels
ethosuximide
lamotrigine
lamictal
also used for bipolar disorder
initial standard dosing: weeks 1 and 2 --> 25mg daily
BBW --> serious skin reactions (SJS/TEN)
warnings --> multiorgan HSR (DRESS)
SEs --> alopecia (supplement with biotin, selenium, and zinc)
notes -->
- use starter kit when initiating treatment
- if DC, restart initial dosing titration
lamotrigine drug interactions
valproic acid can increase lamotrigine; use lower dose starter kit (blue box)
when using drugs that decrease lamotrigine, use the higher dose starter kit (green box)
lamictal starter kits by color
lamotrigine dose needs to be just right --> too much leads to a higher risk of severe rash and too little leads to seizures
blue --> lower starting dose; use if taking valproic acid
orange --> standard starting dose; use if no interacting meds
green --> higher starting dose; use if taking an enzyme inducer (carbamazepine, phenytoin, phenobarbital, primidone) and not taking valproic acid
levetiracetam
keppra
IV:PO --> 1:1
warnings --> psych reactions, including psychotic symptoms, somnolence, fatigue
notes --> no significant drug interactions
topiramate
topamax
also used for migraine prophylaxis
warnings --> metabolic acidosis, oligohidrosis (reduced perspiration), nephrolithiasis, angle-closure glaucoma, hyperammonemia, visual problems, fetal harm
SEs --> somnolence, difficulty with memory/concentration/attention, weight loss, anorexia
monitoring --> bicarbonate, IOP
topiramate drug interactions
non-hormonal contraception is recommended
valproic acid and divalproex
valproate and divalproex (depakote)
therapeutic range --> 50-100
also used for bipolar disorder and migraine prophylaxis
valproate and divalproex BBW
hepatic failure
fetal harm (neural tube defects and decreased IQ scores)
pancreatitis
valproate and divalproex warnings
hyperammonemia (treat with carnitine in symptomatic adults only)
thrombocytopenia
valproate and divalproex SEs
alopecia
N/V
weight changes (gain > loss)
somnolence
tremor
valproate and divalproex monitoring
LFTs (baseline and frequently in the first 6 months)
platelets
valproate drug interactions
can increase levels of lamotrigine and warfarin
use caution with lamotrigine due to risk of rash
lacosamide
vimpat
C-V
warnings --> prolongs PR interval and increases risk of arrhythmias; DRESS
carbamazepine
tegretol
therapeutic range --> 4-12
carbamazepine BBW
serious skin reactions --> HLA-B*1502 allele testing
aplastic anemia and agranulocytosis
carbamazepine CIs
myelosuppression
carbamazepine warnings
hyponatremia (SIADH)
fetal harm
carbamazepine monitoring
CBC with differential
Na
carbamazepine notes
inducer, auto-inducer --> decrease level of other drugs and itself
carbamazepine drug interactions
autoinducer --> will decrease its own levels
strong inducer of CYP3A4 and P-gp --> can decrease levels of warfarin and contraceptives (non-hormonal is recommended)
oxcarbazepine
trileptal
warnings --> HLA-B*1502, hyponatremia
monitoring --> Na
oxcarbazepine drug interactions
not an autoinducer
non-hormonal contraception is recommended
phenytoin/fosphenytoin
phenytoin (dilantin) --> therapeutic range 10-20 (total) or 1-2 (free); IV:PO = 1:1
fosphenytoin (cerebyx) --> prodrug of phenytoin
phenytoin and fosphenytoin BBW
phenytoin IV rate should not exceed 50mg/min and fosphenytoin IV should not exceed 150mg PE/min --> if given faster, cardiac arrythmias can occur
phenytoin and fosphenytoin warnings
extravasation (leading to purple glove syndrome)
avoid if positive for HLA-B*1502
fetal harm
phenytoin and fosphenytoin SEs
dose-related toxicity --> nystagmus, ataxia, diplopia
chronic --> gingival hyperplasia, hepatotoxicity
phenytoin and fosphenytoin monitoring
serum phenytoin concentration
LFTs
IV --> cardiac and respiratory function
phenytoin and fosphenytoin drug interactions
strong inducers of several enzymes
non-hormonal contraception recommended
both have high protein binding
phenytoin/fosphenytoin administration
IV phenytoin -->
- do not exceed 50mg/min
- monitor BP, resp. function, and ECG
- requires a filter
- dilute in NS, stable for 4 hours, do not refrigerate
NG tube phenytoin -->
- enteral feedings decrease phenytoin absorption
- hold feedings 1-2 hours before and after admin
IV fosphenytoin -->
- do not exceed 150mg PE/min
- monitoring same as above
- lower risk of purple glove syndrome than phenytoin
phenytoin monitoring/adjusting doses
the metabolism of phenytoin can become saturated --> a small increase in the dose can lead to a large increase in the drug concentration
phenytoin follows michaelis-menten kinetics, also called saturable kinetics
if albumin is low (<3.5) and CrCl is 10 or higher, adjust the total level with the formula:
phenytoin correction = total phenytoin measured/(0.2 x albumin) + 0.1
free levels do not require correction
phenobarbital
sezaby
therapeutic range --> 20-40 (adults)
warnings --> potential for drug dependency, respiratory depression, fetal harm
SEs --> dependence, tolerance, residual sedation
phenobarbital drug interactiosn
strong inducer
non-hormonal contraception
ASM cousins
carbamazepine, oxcarbazepine, eslicarbazepine --> hyponatremia, rash, enzyme induction
gabapentin and pregabalin --> weight gain, peripheral edema, mild euphoria, used primarily for neuropathic pain
phenobarbital and primidone --> sedation, dependence/tolerance/overdose risk, enzyme induction
topiramate and zonisamide --> weight loss, metabolic acidosis, nephrolithiasis and oligohidrosis/hyperthermia (in children)
benzos
C-IV
BBW --> use with opioids can lead to respiratory depression, death
eslicarbazepine
oxcarbazepine is the active metabolite
can cause decreased Na (monitor)
ethosuximide
used for absence seizures
warnings --> SJS/TEN, blood dyscrasias
felbamate
BBW --> aplastic anemia
fenfluramine
BBW --> valvular heart disease, PAH
warnings --> decreased appetite/weight loss
gabapentin
neurontin
SEs --> somnolence, peripheral edema, weight gain, mild euphoria
notes --> used for neuropathic pain
pregabalin
lyrica
C-V
used for neuropathic pain
primidone
prodrug of phenobarbital
vigabatrin
BBW --> permanent vision loss
zonisamide
CI --> sulfa allergy
SEs --> oligohidrosis/hyperthermia, nephrolithiasis
monitoring
phenytoin, valproic acid, carbamazepine, and phenobarbital have therapeutic drug level ranges
drug interactions
can be caused by protein binding or enzyme-mediated effects
some are highly protein bound (phenytoin, valproate)
many ASMs are enzyme inducers
valproic acid is an enzyme inhibitor
higher lamotrigine levels increases risk for severe rash
ASM enzyme inducers
carbamazepine
oxcarbazepine
phenytoin
fosphenytoin
phenobarbital
primidone
ASM enzyme inhibitors
valproic acid (increases lamotrigine)
use in pregnancy
several ASMs have teratogenicity risk
valproic acid has the highest risk --> NTDs and decreased IQ
levetiracetam has the lowest risk --> preferred in pregnancy
take folate to prevent NTDs
women on ASMs should avoid unplanned pregnancy
many ASMs reduce the efficacy of oral hormonal contraceptives
ASMs contribute to bone loss --> adequate calcium and vitamin D supplementation
ASM levels decline during pregnancy, which can be harmful to the baby
use in children
topiramate and zonisamide can cause reduced sweating --> sun exposure should be limited
lamotrigine-induced rash occurs more commonly in children
use formulations that are easy to swallow --> lamotrigine ODT or chewable tablets, levetiracetam ODT or oral solutions
all ASM counseling
can cause suicidal thoughts or behaviors and drowsiness
seizures can become worse when the drug is suddenly stopped. The dose must be gradually decreased
many drug interactions, including drugs that worsen drowsiness and drugs that lower the seizure threshold
supplement with calcium and vitamin D while taking this med
carbamazepine counseling
can cause severe rash and rare but serious blood disorders. you will need to have your blood checked while on this med
avoid in pregnancy
lamotrigine counseling
can cause severe rash (most likely in the first 2-8 weeks of treatment)
chewable tablets can be swallowed whole, chewed, or mixed in water or diluted juice. if mixed, drink the whole amount right away
oxcarbazepine counseling
can cause low sodium levels. contact your HCP if you experience fatigue, HA, nausea, or confusion
can cause severe rash
take ER (oxtellar XR) on an empty stomach at least one hour before or two hours after food
shake oral suspension for 10 seconds before using. It can be mixed in a small glass of water
phenytoin counseling
can cause severe rash, gingival hyperplasia, changes in vision, abnormal eye movements
avoid in pregnancy
phenobarbital counseling
abuse and dependence can occur
avoid in pregnancy
topiramate counseling
can cause problems with concentration, attention, memory, or speech, eye damage, decreased sweating and increased body temp, and weight loss
sprinkle capsules can be swallowed whole or opened and sprinkled on a teaspoon of soft food. swallow whole; do not chew. follow with a glass of water
drink plenty of fluids to prevent kidney stones
avoid in pregnancy
valproic acid counseling
can cause liver damage and weight gain
avoid in pregnancy
take with food to help avoid stomach upset
diazepam rectal gel counseling
the green ready band should be visible before leaving the pharmacy
admin instructions -->
put the person on their side in a safe place
get med syringe and lubricating jelly
remove syringe cap by pushing up with thumb
apply lubricating jelly to syringe tip
turn the person on their side facing you and bend upper leg forward to expose the rectum
separate buttocks and gently insert syringe tip into the rectum until the rim is snug against the rectal opening
slowly count to 3 while gently pushing the plunger until it stops
count to 3 before removing the syringe from rectum
remove the syringe and count to 3 again while holding the butt together to prevent leakage
make note of the time given and observe
call 911 if seizure continues 15 minutes after giving the medication
to dispose of any medication remaining in the syringe, first remove the plunger from the syringe, then replace it. aim the application tip over the sink or toilet. push the plunger down to remove any remaining medication in the syrinege